Yet H. Khor, MD, PhD, explains why a 20% emphysema threshold on CT imaging may better define combined PF and emphysema in ...
UK Biobank data linked 7-day wrist light sensing to CMR 3.1 years later, contrasting >3 lux nighttime exposure with none.
Fibrotic interstitial lung diseases, like idiopathic pulmonary fibrosis (IPF), commonly overlap with lung cancer—a key ...
Tozorakimab targets IL-33 upstream of TH2 pathways, cutting COPD exacerbations up to 34% in former smokers, Frank Sciurba, MD ...
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) suggests escalating treatment in patients with chronic ...
In "Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD," the mental health experts examined ...
Francesca Puggioni, MD, explains how real-world registry data, like the EU-ADVANTAGE study, informs regulatory decisions on ...
VHA/CMS screening identified 11,809 veterans with PV; after exclusions, 5,287 and 5,245 were analyzed for mortality and ...
Takeda’s oveporexton (Orzeyful), a selective OX2R agonist, is the first therapy targeting orexin deficiency in NT1, improving ...
The One Big Beautiful Bill Act restructures Medicaid coverage in ways that have a direct impact on oncology programs. This ...
In "Inside the Be Well Trials: Design, Population, and Patient Selection," the panel walks through why the Be Well trials ...
In "Cross-Trial Vitiligo Data: What Payers Can and Can't Compare," the panel compares cross-trial data directly and discusses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results